Filtering by:
Thyroid CancerTop Story
Read More
January 12, 2021
Facts & Figures 2021 Reports Another Record-Breaking 1-Year Drop in Cancer Deaths
Read the Cancer Facts & Figures 2021, for the latest estimates, information and statistics for deaths related to cancer.
November 28, 2018
FDA Approves Vitrakvi (Larotrectinib) for Tumors With Certain Genetic Change
For the second time, the US Food and Drug Administration (FDA) has approved a drug to treat tumors with a specific genetic change regardless of the type of cancer. Vitrakvi (larotrectinib) is for adults and children with solid tumors that test positive for NTRK genes, which can help cancerous tumors grow.
May 8, 2018
FDA Approves Drug Combination for Aggressive Type of Thyroid Cancer
The US Food and Drug Administration (FDA) has approved a combination of 2 targeted drugs to treat people with anaplastic thyroid cancer that has a certain type of gene mutation (BRAF V600E) and cannot be completely removed through surgery.